Senior Doctors Call for Crackdown on Home Genetic Testing Kits
By Hannah Devlin,
The Guardian
| 07. 21. 2019
False results have told women they have mutations linked to breast and ovarian cancer.
Senior doctors have called for a crackdown on consumer genetic tests, following an influx of patients who have been wrongly told they are carrying dangerous mutations linked to cancer or other devastating conditions.
Women have been incorrectly informed by companies that they have faulty BRCA genes, which convey a high risk of breast and ovarian cancers. One patient was scheduled for preventive breast-removal surgery after a consumer genetic test suggested she had a BRCA mutation. The surgery was called off at the last moment when an NHS laboratory revealed the result to be a false positive.
Doctors warn that the issue is placing an increasing burden on GP surgeries and NHS genetics clinics, which are left to deal with the fallout when people receive alarming or confusing results.
“The NHS is incredibly irritated by these results because [in the case of BRCA] they’re more often wrong than right,” said Prof Anneke Lucassen, a clinical geneticist at Southampton University and chair of the British Society for Genetic Medicine. Lucassen said it was “terrifying” that one of her patients – and possibly...
Related Articles
By Annika Inampudi, Science | 07.10.2025
Before a baby in the United States reaches a few days old, doctors will run biochemical tests on a few drops of their blood to catch certain genetic diseases that need immediate care to prevent brain damage or other serious...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Elizabeth Dwoskin and Yeganeh Torbati, The Washington Post | 07.16.2025
A group of well-heeled, 30-something women sat down to dinner last spring at a table set with pregnancy-friendly mocktails and orchids, ready to hear a talk about how to optimize their offspring.
Noor Siddiqui, the founder of an embryo-screening start-up...
By Suzanne O'Sullivan, New Scientist | 07.09.2025
Rare diseases are often hard to spot. They can evade detection until irreversible organ damage or disability has already set in. Last month, in the hope of preventing just this type of harm, the UK’s health secretary, Wes Streeting, announced...
